Sign in
4

Changes in Ownership

Chemomab Therapeutics Ltd. Filed Acc 0001178913-26-003004

Chief Executive Officer bought 9,804 shares at an average $2.07 ($20,246)

  • Chief Executive Officer disposed of 50,462 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Mor George Adi · Chief Executive Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-05-29 Purchase : show line 1 in the form −4,878 $2.05 $10,000 134,205 D
2026-05-29 Purchase : show line 2 in the form −4,926 $2.08 $10,246 139,131 D
2026-05-29 Other disposition : show line 3 in the form −31,712 31,712 D
2026-05-29 Other disposition : show line 4 in the form −18,750 18,750 D
Open-market purchases · 9,804 sh · avg $2.07 · $20,246
Loading xslF345X06/ownership.xml…